Abstract
To the Editor: An editorial by Dr. Zelis (April 15 issue)1 commented that diltiazem therapy had a low incidence of side effects, and recent randomized clinical trials support this statement.2 , 3 However, I wish to record four case histories that illustrate problems caused by the effect of diltiazem on atrioventricular conduction.4 Case 1 was a 33-year-old Japanese woman with Takayasu's arteritis and angina, who had arteriographic documentation of coronary spasm of the left anterior descending and diagonal branches provoked by ergonovine. The P—R interval was normal, and pretreatment Holter monitoring showed ST-segment changes with pain and no conduction abnormalities. Intermittent . . .